radiopharmaceutical


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

radiopharmaceutical

[‚rād·ē·ō‚fär·mə′süd·ə·kəl]
(pharmacology)
A radioactive drug used for medicinal purposes, either diagnostic or therapeutic.
References in periodicals archive ?
Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases.
Under the new contract, Syncor will become the sole supplier of radiopharmaceuticals to AmeriNet.
com/research/7873ad/global_radiopharma) has announced the addition of the "Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) - Current Trends & Forecasts (2010 - 2015)" report to their offering.
The research service attempts to spot trends, identify market dynamics and challenges and evaluate the European contrast media and radiopharmaceuticals market.
com/research/c3vlm5/global) has announced the addition of the "Global Radiopharmaceuticals Market Insight" report to their offering.
INDIANAPOLIS -- Positron Corporation (OTCBB:POSC), announced it has signed an agreement with Covidien (NYSE:COV), a leading global provider of healthcare products, under which Covidien will provide technical assistance to Positron in connection with Positron's development of technology to automate the compounding of radiopharmaceuticals.
Commonly Used Diagnostic Radiopharmaceutical Agents II-38
It is because of this feature that the demand for radioisotopes or otherwise called radiopharmaceuticals is increasing significantly.
Table 4: US Diagnostic Radiopharmaceutical Agents Market (2007 & 2009): Breakdown of Procedure Volume By Imaging Procedure - SPECT (Cardiac, Others) and PET (In Thousands) (includes corresponding Graph/Chart) II-30
Oliverio also went on to state, "that our new PosiRx[TM] solution will set a new industry standard for the distribution of radiopharmaceuticals giving Positron a significant market share in the massive radiopharmaceutical and imaging device market.
New Imaging Agent for Radiopharmaceutical Scans II-25